Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep 1;1(4):307-316.
doi: 10.1002/mdc3.12063. eCollection 2014 Dec.

Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review

Eugene Y H Yeung  1 , Andrea E Cavanna  1   2   3   4
Affiliations
Review

Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review

Eugene Y H Yeung et al. Mov Disord Clin Pract. .

Abstract

Dopaminergic medications are used as first-line treatment for Parkinson's disease (PD). In 1999, a case series was published describing 9 patients who took dopamine agonists (pramipexole or ropinirole) and experienced sudden irresistible sleep attacks. Sleep attacks have subsequently been reported with other dopaminergic medications, including levodopa. Because these symptoms might not be rare and can affect health-related quality of life, we set out to review the prevalence and clinical characteristics of sleep attacks in patients with PD on dopaminergic medications. We conducted a systematic literature review using the terms parkinson* AND dopamine* AND narcolep* OR sleep attack in multiple databases (PubMed, Embase, and PsycINFO). The systematic literature review yielded 23 relevant articles, including nine case reports or case series and 14 original studies. According to the pooled data from the five studies reporting prevalence figures (n = 10,084), sleep attacks occur in 13.0% of patients with PD on dopaminergic medications. Our analysis failed to show significant differences in the Epworth Sleepiness scores between patients with and without sleep attacks (mean difference: 2.92; 95% confidence interval: -0.47-6.31). The I2 value of 76% indicated high heterogeneity among the studies. Sleep attacks are not a rare occurrence in patients with PD on dopamine agonist treatment. We found conflicting results on whether sleep attacks in PD resemble narcolepsy. The pathophysiology of these symptoms might be related to dopamine D2 and D4 receptor gene polymorphisms. The most effective management strategies were dose reduction and discontinuation of the offending drugs.

Keywords: Parkinson's disease; dopamine; medication; nonmotor symptoms; sleep attacks.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart illustrating the study selection process for the systematic literature review. PICOS, Participants, Intervention, Comparator, Outcome, Study Design.
Figure 2
Figure 2
Forest plot of the studies reporting ES scores. SD, standard deviation.
Figure 3
Figure 3
Funnel plot of the studies reporting ES scores.
See this image and copyright information in PMC

References

    1. Chen JJ, Nelson MV, Swope DM. Parkinson's disease In: Dipiro JT, ed. Pharmacotherapy: A Pathophysiologic Approach. New York: The McGraw‐Hill Companies, Inc.; 2008:977–988.
    1. Grosset DG, Macphee GJ, Nairn M; Guideline Development Group . Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ 2010;340:b5614. - PubMed
    1. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52:1908–1910. - PubMed
    1. Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003;18:659–667. - PubMed
    1. Homann CN, Wenzel K, Suppan K, Ivanic G, Kriechbaum N, Crevenna R, Ott E. Sleep attacks in patients taking dopamine agonists: review. BMJ 2002;324:1483–1487. - PMC - PubMed